<< Back To Search

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
This is the first time doctors have tried using a drug called tasquinimod to treat people with a type of cancer called multiple myeloma. They want to see if the drug works.
*Third Opinion AI Generated Synopsis

Trial Summary
This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?